| Name: | Clindamycin phosphate EP Impurity H |
| Catalogue No. | VE005867 |
| CAS No. | N/A |
| Molecular Formula | C18H35ClN2O11P2S |
| Molecular Weight | 584.94 |
| Status | In-stock |
| IUPAC Name | Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl] carbonyl]amino]-2,3-di-O-phosphono-1-thio-L-threo-α-D-galacto-octopyranoside |
| Synonyms | Clindamycin 2,3 diphosphate / Clindamycin phosphate BP Impurity H |
| Appearance | Off White powder |
| Description | Clindamycin phosphate EP Impurity H or Clindamycin 2,3 diphosphate / Clindamycin phosphate BP Impurity H or Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl] carbonyl]amino]-2,3-di-O-phosphono-1-thio-L-threo-α-D-galacto-octopyranoside. Clindamycin is a lincosamide antibiotic. It is bacteriostatic and inhibit protein synthesis in sensitive bacteria. |
| References | "Spížek, J., and T. Řezanka. “Lincomycin, Clindamycin and Their Applications.” Applied Microbiology and Biotechnology, vol. 64, no. 4, Feb. 2004, pp. 455–64, https://doi.org/10.1007/s00253-003-1545-7. " |
